BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Glassman PM, Myerson JW, Ferguson LT, Kiseleva RY, Shuvaev VV, Brenner JS, Muzykantov VR. Targeting drug delivery in the vascular system: Focus on endothelium. Adv Drug Deliv Rev 2020;157:96-117. [PMID: 32579890 DOI: 10.1016/j.addr.2020.06.013] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 13.5] [Reference Citation Analysis]
Number Citing Articles
1 Charó N, Jerez H, Tatti S, Romero EL, Schattner M. The Anti-Inflammatory Effect of Nanoarchaeosomes on Human Endothelial Cells. Pharmaceutics 2022;14:736. [DOI: 10.3390/pharmaceutics14040736] [Reference Citation Analysis]
2 Qian Y, Kumar R, Chug MK, Massoumi H, Brisbois EJ. Therapeutic Delivery of Nitric Oxide Utilizing Saccharide-Based Materials. ACS Appl Mater Interfaces 2021. [PMID: 34714640 DOI: 10.1021/acsami.1c10964] [Reference Citation Analysis]
3 Gifre-Renom L, Daems M, Luttun A, Jones EAV. Organ-Specific Endothelial Cell Differentiation and Impact of Microenvironmental Cues on Endothelial Heterogeneity. Int J Mol Sci 2022;23:1477. [PMID: 35163400 DOI: 10.3390/ijms23031477] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
4 Hussain B, Kasinath V, Madsen JC, Bromberg J, Tullius SG, Abdi R. Intra-Organ Delivery of Nanotherapeutics for Organ Transplantation. ACS Nano 2021. [PMID: 34714050 DOI: 10.1021/acsnano.1c04707] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
5 Yu L, Dai Y, Mineo C. Novel Functions of Endothelial Scavenger Receptor Class B Type I. Curr Atheroscler Rep 2021;23:6. [PMID: 33420646 DOI: 10.1007/s11883-020-00903-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
6 Fu L, Kim HN, Sterling JD, Baker SM, Lord MS. The role of the cell surface glycocalyx in drug delivery to and through the endothelium. Adv Drug Deliv Rev 2022;184:114195. [PMID: 35292326 DOI: 10.1016/j.addr.2022.114195] [Reference Citation Analysis]
7 Skaria T, Bachli E, Schoedon G. Transcriptional Regulation of Drug Metabolizing CYP Enzymes by Proinflammatory Wnt5A Signaling in Human Coronary Artery Endothelial Cells. Front Pharmacol 2021;12:619588. [PMID: 34079452 DOI: 10.3389/fphar.2021.619588] [Reference Citation Analysis]
8 Yin M, Li C, Jiang J, Le J, Luo B, Yang F, Fang Y, Yang M, Deng Z, Ni W, Shao J. Cell adhesion molecule-mediated therapeutic strategies in atherosclerosis: From a biological basis and molecular mechanism to drug delivery nanosystems. Biochem Pharmacol 2021;186:114471. [PMID: 33587918 DOI: 10.1016/j.bcp.2021.114471] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Hussain Y, Cui JH, Khan H, Makvandi P, Alam W. Biomacromolecule-mediated pulmonary delivery of siRNA and anti-sense oligos: challenges and possible solutions. Expert Rev Mol Med 2021;23:e22. [PMID: 34906269 DOI: 10.1017/erm.2021.25] [Reference Citation Analysis]
10 Neto E, Monteiro AC, Leite Pereira C, Simões M, Conde JP, Chu V, Sarmento B, Lamghari M. Micropathological Chip Modeling the Neurovascular Unit Response to Inflammatory Bone Condition. Adv Healthc Mater 2022;11:e2102305. [PMID: 35158409 DOI: 10.1002/adhm.202102305] [Reference Citation Analysis]
11 Ju Y, Guo H, Edman M, Hamm-Alvarez SF. Application of advances in endocytosis and membrane trafficking to drug delivery. Adv Drug Deliv Rev 2020;157:118-41. [PMID: 32758615 DOI: 10.1016/j.addr.2020.07.026] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
12 Zhang L, Li Z, Ye X, Chen Z, Chen ZS. Mechanisms of thrombosis and research progress on targeted antithrombotic drugs. Drug Discov Today 2021:S1359-6446(21)00210-5. [PMID: 33895314 DOI: 10.1016/j.drudis.2021.04.023] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Wang W, Teng Y, Xue J, Cai H, Pan Y, Ye X, Mao X, Li S. Nanotechnology in Kidney and Islet Transplantation: An Ongoing, Promising Field. Front Immunol 2022;13:846032. [DOI: 10.3389/fimmu.2022.846032] [Reference Citation Analysis]
14 Jarai BM, Stillman Z, Bomb K, Kloxin AM, Fromen CA. Biomaterials-Based Opportunities to Engineer the Pulmonary Host Immune Response in COVID-19. ACS Biomater Sci Eng 2021;7:1742-64. [PMID: 33356134 DOI: 10.1021/acsbiomaterials.0c01287] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
15 Nong J, Glassman PM, Muzykantov VR. Targeting vascular inflammation through emerging methods and drug carriers. Adv Drug Deliv Rev 2022;184:114180. [PMID: 35271986 DOI: 10.1016/j.addr.2022.114180] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Milošević N, Rütter M, David A. Endothelial Cell Adhesion Molecules- (un)Attainable Targets for Nanomedicines. Front Med Technol 2022;4:846065. [DOI: 10.3389/fmedt.2022.846065] [Reference Citation Analysis]
17 Yang Q, Wijerathne H, Langston JC, Kiani MF, Kilpatrick LE. Emerging Approaches to Understanding Microvascular Endothelial Heterogeneity: A Roadmap for Developing Anti-Inflammatory Therapeutics. Int J Mol Sci 2021;22:7770. [PMID: 34360536 DOI: 10.3390/ijms22157770] [Reference Citation Analysis]
18 de Castro Leão M, Raffin Pohlmann A, de Cristo Soares Alves A, Helena Poliselli Farsky S, Klimuk Uchiyama M, Araki K, Sandri S, Stanisçuaski Guterres S, Alves Castro I. Docosahexaenoic acid nanoencapsulated with anti-PECAM-1 as co-therapy for atherosclerosis regression. Eur J Pharm Biopharm 2021;159:99-107. [PMID: 33358940 DOI: 10.1016/j.ejpb.2020.12.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Dunaway LS, Pollock JS. HDAC1: an environmental sensor regulating endothelial function. Cardiovasc Res 2021:cvab198. [PMID: 34264338 DOI: 10.1093/cvr/cvab198] [Reference Citation Analysis]
20 Li X, Zhang Y, Ren X, Wang Y, Chen D, Li Q, Huo M, Shi J. Ischemic Microenvironment-Responsive Therapeutics for Cardiovascular Diseases. Adv Mater 2021;33:e2105348. [PMID: 34623714 DOI: 10.1002/adma.202105348] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
21 Bae J, Choi YS, Cho G, Jang SJ. The Patient-Derived Cancer Organoids: Promises and Challenges as Platforms for Cancer Discovery. Cancers (Basel) 2022;14:2144. [PMID: 35565273 DOI: 10.3390/cancers14092144] [Reference Citation Analysis]
22 Tran TTT, Delgado A, Jeong S. Organ-on-a-Chip: The Future of Therapeutic Aptamer Research? BioChip J 2021;15:109-22. [DOI: 10.1007/s13206-021-00016-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
23 Ioannidou A, Fisher RM, Hagberg CE. The multifaceted roles of the adipose tissue vasculature. Obes Rev 2021;:e13403. [PMID: 34866318 DOI: 10.1111/obr.13403] [Reference Citation Analysis]
24 Ferguson LT, Hood ED, Shuvaeva T, Shuvaev VV, Basil MC, Wang Z, Nong J, Ma X, Wu J, Myerson JW, Marcos-Contreras OA, Katzen J, Carl JM, Morrisey EE, Cantu E, Villa CH, Mitragotri S, Muzykantov VR, Brenner JS. Dual Affinity to RBCs and Target Cells (DART) Enhances Both Organ- and Cell Type-Targeting of Intravascular Nanocarriers. ACS Nano 2022;16:4666-83. [PMID: 35266686 DOI: 10.1021/acsnano.1c11374] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
25 Khakinahad Y, Sohrabi S, Razi S, Narmani A, Khaleghi S, Asadiyun M, Jafari H, Mohammadnejad J. Margetuximab conjugated-PEG-PAMAM G4 nano-complex: a smart nano-device for suppression of breast cancer. Biomed Eng Lett . [DOI: 10.1007/s13534-022-00225-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Meng Z, Wang H, Fang X, Liu Z, Yang Z, Yong J, Yang Q, Bai Y, Ren H, Xu H, Li X. Surface Decoration via Physical Interaction of Cupric Diethyldithiocarbamate Nanocrystals and Its Impact on Biodistribution and Tumor Targeting. ACS Appl Mater Interfaces 2021;13:36894-908. [PMID: 34328715 DOI: 10.1021/acsami.1c09346] [Reference Citation Analysis]